Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.USPTO extends Spectrum Folotyn patent for five years
The extension, which was granted through the Hatch-Waxman Act, postpones the original 16 July 2017 expiration date to 16 July 2022. Spectrum Pharmaceuticals chairman, president and chief executive
The extension, which was granted through the Hatch-Waxman Act, postpones the original 16 July 2017 expiration date to 16 July 2022. Spectrum Pharmaceuticals chairman, president and chief executive
The study, being conducted in collaboration with PATH that will fund approximately $2m to support the trial, will evaluate the immunogenicity and safety of two dose levels of
The MGH and Sanofi will include both pre-clinical and clinical translational research to explain questions from proof-of-concept to tolerability, efficacy and effectiveness. Sanofi Oncology senior vice president and
Cevimeline hydrochloride is indicated for the treatment of dry mouth symptoms associated with Sjogren’s syndrome, an autoimmune disorder affecting the moisture-producing glands. Ranbaxy CEO and managing director Arun
The SBIR contract will also allow the company to conduct studies to file an Investigational New Drug (IND) Application with the FDA in the next two years for
Encap is a contract development and manufacturing organisation which has applied liquid and semi-solid filled hard capsules for pharmaceutical products. Encap Drug Delivery research and development director Jane
CEConnection.com, an online platform provides institutions peer-reviewed content from LWW journals and products, which make it easy to offer and track CE course completion by practitioners. CEConnection in
The Forfivo XL, which the company claims, is the only available 450mg dose of an extended-release bupropion product and is intended for the treatment of major depressive disorder
The announcement follows the presentation of EXPEDITION study data conducted by the Alzheimer’s Disease Cooperative Study (ADCS), an academic research consortium, at the annual meeting of the American
BioVigilant’s IMD-A 300 and IMD-A 350 systems are used to detect bacteria presence in the aseptic manufacturing process. Ophthalmic pharmacist Charles Leiter said Azbil BioVigilant’s IMD-A system will